Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Iyas Daghlas: Contemporary Rates of Ischemic Stroke Following High-Risk TIA
Iyas Daghlas; Michelle Caunca/LinkedIn, Anthony Kim/UCSF
Feb 21, 2026, 12:42

Iyas Daghlas: Contemporary Rates of Ischemic Stroke Following High-Risk TIA

Iyas Daghlas, Vascular Neurology Fellow and Stroke Researcher at the University of California, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:

”Our new paper, now out in JAHA — Journal of the American Heart Association, revisits contemporary rates of ischemic stroke following high-risk TIA.

This analysis was motivated by the notion that ABCD2 scores estimate the ‘pre-treatment’ risk of ischemic stroke.

In high-risk patients, these estimates do not incorporate the impact of highly effective contemporary therapies (namely dual antiplatelet therapy).

Indeed, the selection of high-risk patients for potential admission is best informed by the ‘post-treatment’ / residual risk of ischemic stroke after DAPT.

Using high-quality data from the pivotal POINT trial, we aimed to quantify residual ischemic stroke risk following DAPT in patients with high-risk TIA.

What we found:

  • As expected, the residual stroke risk is several fold lower than the risk predicted by ABCD2 (2 days: 1.3% vs 5.1%)
  • In fact, the observed risk now approximates what we traditionally consider “low-risk” ABCD2 strata (2 day risk historical estimate: 1%)
  • Absence of infarction on baseline neuroimaging reduces risk even further—down to 0.8% at 2 days – further highlighting that neuroimaging can powerfully stratify/reclassify risk in patients with clinically diagnosed TIA on the basis of resolved symptoms (many of whom actually have strokes!)

Although ABCD2 may remain useful for identifying patients who benefit from treatment, its historical risk estimates ‘substantially overstate’ risk in patients receiving contemporary therapy.

This raises the question – if residual risk after treatment is this low, is hospital admission for monitoring cost-effective or necessary?

(Diagnostic evaluation is a separate consideration..).

Lastly, these event rates (or lack thereof) may be helpful for planning future clinical trials of high-risk TIA patients.

Grateful to coauthors Michelle Caunca and Anthony Kim!!”

Title: Observed Versus Predicted Stroke Risk After Transient Ischemic Attack: A Post Hoc Analysis of a Randomized Clinical Trial

Authors: Iyas Daghlas, Michelle Caunca, Anthony Kim

Read the Full Article on Journal of the American Heart Association

Iyas Daghlas: Contemporary Rates of Ischemic Stroke Following High-Risk TIA

Stay updated on all scientific advances with Hemostasis Today.

Anthony Kim Health Hematology Hemostasis Hemostasis News Hemostasis Today Iyas Daghlas JAHA Journal of the American Heart Association Medicine Michelle Caunca POINT stroke thrombosis TIA
NewsFeed